New Major Order From China

STOCKHOLM, Sept. 29, 2019 /PRNewswire/ — Bactiguard has received a new order from Well Lead Medical (Well Lead) in China. The order will be delivered promptly and generate revenues in the third quarter of approximately SEK 4,8 million.

“The order we have just received from Well Lead is the first outside of the initial contract and therefore an important milestone in our cooperation, as it shows that end-customer sales in China are picking up”, says Christian Kinch, CEO.

In June 2018, Bactiguard signed a combined distribution and license agreement with Well Lead, China’s leading manufacturer of consumable medical devices.

The first two product orders, at a combined value of SEK 20 million, were part of the initial contract and delivered in the second and fourth quarters of 2018. The third order, which has now been received, is worth SEK 4,8 million and it is the first order outside the initial contract.

This information is information that Bactiguard Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below 2019-09-29, at 20:00

For further information, please contact:

Cecilia Edström
CFO and deputy CEO
mobile: +46-722-262-328

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/bactiguard-holding-ab–publ-/r/new-major-order-from-china,c2920728

The following files are available for download:

https://mb.cision.com/Main/9686/2920728/1115431.pdf

190929 New major order from China

View original content:http://www.prnewswire.com/news-releases/new-major-order-from-china-300927429.html

SOURCE Bactiguard Holding AB (publ)

user

Recent Posts

Creative Medical Technology Holdings Provides Corporate Update

PHOENIX--(BUSINESS WIRE)--Creative Medical Technology Holdings, Inc., (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a…

2 hours ago

GE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist

Prostate Volume Assist (PVA) is the company’s proprietary urology-based artificial intelligence (AI) software feature designed…

2 hours ago

Sutter Health Partners with Abridge on Generative AI Solution to Improve Patient, Physician Experience

PITTSBURGH & SACRAMENTO, Calif.--(BUSINESS WIRE)--Today, Abridge and Sutter Health announced they will make Abridge’s generative…

2 hours ago

Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting

Presentations Will Feature Studies Evaluating TENEO™ Excimer Laser Platform, MIEBO® (Perfluorohexyloctane Ophthalmic Solution) and enVista®…

2 hours ago

Blackstone Life Sciences Announces Collaboration to Support Moderna’s Influenza Program

Blackstone Life Sciences to invest up to $750 million to support innovative mRNA technologyNEW YORK--(BUSINESS…

2 hours ago

Male Contraceptive Initiative Marks Women’s History Month With Investment in Birth Control Pill for Men

Phase 1a study of first hormone-free male pill completes enrollmentDURHAM, NC / ACCESSWIRE / March…

2 hours ago